DOI QR코드

DOI QR Code

A case of fatal pneumococcal 19A meningoencephalitis despite administration of seven-valent pneumococcal conjugate vaccines

7가 페구균백신 접종에도 치명적인 폐구균 19A 수막염 1예

  • Heo, Ah Rum (Department of Pediatrics, Masan Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Lee, Jun Hwa (Department of Pediatrics, Masan Samsung Hospital, Sungkyunkwan University School of Medicine)
  • 허아름 (성균관대학교 마산삼성병원 소아청소년과) ;
  • 이준화 (성균관대학교 마산삼성병원 소아청소년과)
  • Received : 2008.09.09
  • Accepted : 2008.11.09
  • Published : 2009.04.15

Abstract

Streptococcus pneumoniae is a major cause of serious invasive diseases in children, especially in young infants, but seven- valent pneumococcal conjugate vaccine (PCV7) is believed to prevent invasive pneumococcal pneumonia and meningitis in young children. However, recently, the incidence of non-PCV7 serotype has increased after PCV7 vaccination. A 14-month- old female patient presented at our emergency room with mental change and lethargy. Three days previously, she had developed fever and vomiting. After being admitted, she rapidly progressed to coma and brain death despite prompt and extensive supportive treatment. She expired 20 days after admission with a final diagnosis of pneumococcal 19A (non-PCV7 serotype) meningoencephalitis despite having received PCV7 ($Prevenar^{(R)}$) vaccinations on three occasions. The author reports this first fatality due to pneumococcal 19A meningoencephalitis in Korea and provides a brief review of the literature.

폐구균(Streptococcus pneumoniae)은 소아, 특히 어린 영아에서 심한 침습성 질병을 일으키는 중요한 원인균이다. 2003년부터 우리나라에서 접종하기 시작한 7가 폐구균백신(PCV7)은 소아에서 침습성 폐구균성 폐렴과 수막염을 예방하는 것으로 알려져 왔다. 그러나 최근 7가 폐구균백신을 접종한 이후부터 비7가 폐구균 혈청형(non-PCV7 serotype) 감염 발생률이 증가하고 있다. 14개월 된 여아가 내원 3일 전부터 열과 구토가 있었으나 증상 치료만 하고 있던 중 갑작스런 의식불명과 기면(lethargy)으로 응급실로 내원하였다. 입원 후 즉각적인 진단과 치료를 시행했음에도 불구하고 환자는 빠르게 혼수와 뇌사 상태로 진행하였다. 환자는 이전에 3회의 7가 폐구균백신을 접종하였으나 최종 진단은 비7가 폐구균 혈청형인 폐구균 19A 수막염이었고, 입원 20일째 사망하였다. 이는 한국에서 문헌상 보고된 적이 없는, 폐구균 19A 혈청형 수막염으로 사망한 첫번째 증례이므로 이에 보고하는 바이다.

Keywords

References

  1. Albrich WC, Baughman W, Schmotzer B, Farley MM. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7- valent pneumococcal conjugate vaccine. Clin Infect Dis 2007 ;44:1569-76 https://doi.org/10.1086/518149
  2. Munoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia- Garcia JJ, Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7- valent conjugate vaccine. Clin Infect Dis 2008;46:174-82 https://doi.org/10.1086/524660
  3. Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 2007;3:e168 https://doi.org/10.1371/journal.ppat.0030168
  4. Centers for Disease Control and Prevention(CDC). Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. MMWR Morb Mortal Wkly Rep 2008;57:144-8
  5. Kaplan SL, Mason EO Jr, Wald ER, Schulze GE, Bradley JS, Tan TQ et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004;113:443-9 https://doi.org/10.1542/peds.113.3.443
  6. Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006;368:1495 -502 https://doi.org/10.1016/S0140-6736(06)69637-2
  7. Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006;295:1668-74 https://doi.org/10.1001/jama.295.14.1668
  8. Von Kries R, Hermann M, Al-Lahham A, Siedler A, Reinert RR. Will the 7-valent pneumococcal vaccine have a similar impact on all invasive pneumococcal infections in children in Germany as in the Kaiser Permanente Trial? Eur J Pediatr 2002;161(Suppl 2:)S140-3
  9. Bricks LF, Berezin E. Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases. J Pediatr (Rio J) 2006;82(Suppl 3):67-74
  10. Lee CJ, Fraser BA. The structures of the cross-reactive types 19 (19F) and 57 (19A) pneumococcal capsular polysaccharides. J Biol Chem 1980;255:6847-53
  11. Jakobsen H, Sigurdsson VD, Sigurdardottir S, Schulz D, Jonsdttir I. Pneumococcal serotype 19F conjugate vaccine induces cross-protective immunity to serotype 19A in a murine pneumococcal pneumonia model. Infect Immun 2003; 71:2956-9 https://doi.org/10.1128/IAI.71.5.2956-2959.2003
  12. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007;297:1784-92 https://doi.org/10.1001/jama.297.16.1784
  13. Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J, et al. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 2007;26:468-72 https://doi.org/10.1097/INF.0b013e31803df9ca
  14. Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, et al. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J 2007;26:461-7 https://doi.org/10.1097/INF.0b013e31805cdbeb
  15. Farrell DJ, Klugman KP, Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J 2007;26:123-8 https://doi.org/10.1097/01.inf.0000253059.84602.c3
  16. Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee JH, et al. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 2008;14:275-81 https://doi.org/10.3201/eid1402.070807